Literature DB >> 12557269

Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain.

Svetlana I Chefer1, Edythe D London, Andrei O Koren, Olga A Pavlova, Varughese Kurian, Alane S Kimes, Andrew G Horti, Alexey G Mukhin.   

Abstract

External imaging of nicotinic acetylcholine receptors (nAChRs) using techniques such as PET would help to clarify the roles of these receptors in the physiology and pathology of brain function. Here we report the results of quantitative PET studies of cerebral nAChRs with 2-[(18)F]fluoro-A-85380 (2-[(18)F]FA) in rhesus monkeys. Data from dynamic PET scans were analyzed using graphical methods. Binding potential (BP) values of 2.0, 0.4, 0.3, and 0.03 observed in the thalamus (Th), cortex (Cx), striatum (Str), and cerebellum (Cb), respectively, were consistent with the pattern of alpha(4)beta(2) nAChR distribution in monkey brain. The high value of 2-[(18)F]FA-specific binding in the rhesus monkey Th and low level of that in Cb compared with nonspecific accumulation of radioactivity in these structures allowed use of Cb as a reference region for calculation of BP and volume of distribution of specific binding (VDsb) in Th by graphical methods, both with and without the plasma input function. In contrast, estimation of 2-[(18)F]FA specific binding in low-receptor-density regions such as Cx and Str required assessment of nondisplaceable volume of distribution (VDnd) in a separate study and measurement of nonmetabolized radioligand concentrations in the plasma. For accurate quantitation of 2-[(18)F]FA-specific binding by graphical analysis, PET studies should last up to 7 h due to the slow kinetics of 2-[(18)F]FA brain distribution. Further, to avoid substantial underestimation in measured BP values the doses of administered 2-[(18)F]FA should not exceed 0.1 nmol/kg body weight. The findings suggest that 2-[(18)F]FA is a promising ligand for quantitation of nAChRs in human brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12557269     DOI: 10.1002/syn.10180

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  26 in total

1.  Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).

Authors:  Rama Pichika; Balu Easwaramoorthy; Bradley T Christian; Bingzhi Shi; Tanjore K Narayanan; Daphne Collins; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2011-08-09       Impact factor: 2.408

2.  Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.

Authors:  Alane S Kimes; Svetlana I Chefer; John A Matochik; Carlo S Contoreggi; D Bruce Vaupel; Elliot A Stein; Alexey G Mukhin
Journal:  Neuroimage       Date:  2007-09-19       Impact factor: 6.556

3.  Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates.

Authors:  Bernard Le Foll; Svetlana I Chefer; Alane S Kimes; Elliot A Stein; Steven R Goldberg; Alexey G Mukhin
Journal:  Psychopharmacology (Berl)       Date:  2016-02-25       Impact factor: 4.530

4.  Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey.

Authors:  A T Hillmer; D W Wooten; J M Moirano; M Slesarev; T E Barnhart; J W Engle; R J Nickles; D Murali; M L Schneider; J Mukherjee; B T Christian
Journal:  Synapse       Date:  2011-08-31       Impact factor: 2.562

5.  Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.

Authors:  Rama Pichika; Sharon A Kuruvilla; Narmisha Patel; Kenny Vu; Sangamitra Sinha; Balu Easwaramoorthy; Tanjore K Narayanan; Bingzhi Shi; Bradley Christian; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2012-11-07       Impact factor: 2.408

6.  Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.

Authors:  Arthur L Brody; Mark A Mandelkern; Edythe D London; Richard E Olmstead; Judah Farahi; David Scheibal; Jennifer Jou; Valerie Allen; Emmanuelle Tiongson; Svetlana I Chefer; Andrei O Koren; Alexey G Mukhin
Journal:  Arch Gen Psychiatry       Date:  2006-08

7.  Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.

Authors:  Frederic Bois; Jean-Dominique Gallezot; Ming-Qiang Zheng; Shu-Fei Lin; Irina Esterlis; Kelly P Cosgrove; Richard E Carson; Yiyun Huang
Journal:  Nucl Med Biol       Date:  2014-08-08       Impact factor: 2.408

8.  Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions.

Authors:  Hiroto Kuwabara; Yongjun Gao; Michael Stabin; Jennifer Coughlin; Sridhar Nimmagadda; Robert F Dannals; Martin G Pomper; Andrew G Horti
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 9.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

Review 10.  Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Authors:  Agnes J Jasinska; Todd Zorick; Arthur L Brody; Elliot A Stein
Journal:  Neuropharmacology       Date:  2013-03-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.